Department of Biology, Faculty of Science and Technology, Rajamangala University, Thanyaburi, Pathum Thani, 12110, Thailand.
Department of Biology, Faculty of Science, Mahasarakham University, 44150, Thailand.
J Ethnopharmacol. 2020 Nov 15;262:113128. doi: 10.1016/j.jep.2020.113128. Epub 2020 Jul 28.
Plants are the source of medication for preventive, curative, protective or promotive purposes. Medicinal plants are an important source for generating of novel phytomedicine. They provide profound therapeutic benefits, more affordable treatments, effectiveness, less side effects and relatively low cost or less expensive and globally competitive. Using plant derived medicine is also relatively safe compared to synthetic medicines. Many plants have proved to successfully aid in the treatment of ailments including Sphagneticola triolobata (L.) Pruski.
This study was therefore, designed to investigate acute and subacute toxicities, antidiabetic activity and also antioxidant activity of flower extract from S. triolobata (L.) Pruski.
This research investigates the toxicity and antidiabetic activity of Sphagnelicola trilobata (L.) Pruski flower ethanolic extract in rats. Acute toxicity was determined by a single oral administration of S. trilobata extract of 1500, 2000, and 2500 mg/kg body weight; and subacute toxicity by oral administration every two days for 14 days. Signs of toxicity and mortality were observed during 24 h and for 14 days. Hematological values and blood chemistry were also characterized. The antidiabetic activity was examined by orally administering S. trilobata extract of 250 mg/kg body weight to streptozotocin-induced diabetic rats on a daily basis for eight weeks; and the body weight, blood glucose, serum insulin, and lipid profiles were determined. The antioxidant activity of the extract was assessed by 1, 1-diphenyl-2-picryl-hydrazyl free radical scavenging assay.
The results demonstrated a median lethal dose (LD) greater than 2500 mg/kg since there was no sign of toxicity and mortality in acute and subacute toxicity testing. The high LD indicated that S. trilobata flower ethanolic extract is safe for treatment of diabetes. There was no significant change in the body weight, hematological values, and blood chemistry of treated rats, compared with the control group. The diabetes-induced rats showed a significant reduction in blood glucose and triglyceride (p < 0.05). Meanwhile, the antioxidant activity of S. trilobata extract was lower than that of standard ascorbic acid.
植物是预防、治疗、保护或促进目的药物的来源。药用植物是产生新型植物药的重要来源。它们提供了深远的治疗益处、更实惠的治疗方法、有效性、较少的副作用和相对较低的成本或较低的价格以及全球竞争力。与合成药物相比,使用植物衍生药物也相对安全。许多植物已被证明可成功帮助治疗疾病,包括 Sphagneticola triolobata (L.) Pruski。
因此,本研究旨在研究三裂叶节节菜(L.)Pruski 花提取物的急性和亚急性毒性、降血糖活性和抗氧化活性。
本研究调查了三裂叶节节菜(L.)Pruski 花乙醇提取物在大鼠中的毒性和降血糖活性。急性毒性通过单次口服 1500、2000 和 2500mg/kg 体重的三裂叶节节菜提取物来确定;亚急性毒性通过每两天口服一次,共 14 天来确定。在 24 小时和 14 天内观察毒性和死亡率的迹象。还对血液学值和血液化学进行了表征。通过每天口服 250mg/kg 体重的三裂叶节节菜提取物,对链脲佐菌素诱导的糖尿病大鼠进行 8 周的糖尿病活性检查,并测定体重、血糖、血清胰岛素和血脂谱。通过 1,1-二苯基-2-苦基肼自由基清除测定法评估提取物的抗氧化活性。
结果表明,中位致死剂量(LD)大于 2500mg/kg,因为在急性和亚急性毒性试验中没有毒性和死亡率的迹象。高 LD 表明三裂叶节节菜花乙醇提取物可安全用于治疗糖尿病。与对照组相比,治疗大鼠的体重、血液学值和血液化学值没有显著变化。糖尿病诱导的大鼠血糖和甘油三酯显著降低(p < 0.05)。同时,三裂叶节节菜提取物的抗氧化活性低于标准抗坏血酸。